Manila Gaddh, MD

Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of Life.

Chest

Primary Care Clinicians' Prescribing Patterns of Reduced-Dose Direct Oral Anticoagulants for Extended-Phase Venous Thromboembolism Treatment.

Journal of clinical medicine

Comparison of Venous Thromboembolism Outcomes after COVID-19 and Influenza Vaccinations.

TH open : companion journal to thrombosis and haemostasis

Combined immunosuppression for acquired hemophilia A: CyDRi is a highly effective low-toxicity regimen.

Blood

Comparing direct oral anticoagulants and vitamin K antagonist use in morbidly obese patients with venous thromboembolism: A single center retrospective cohort study.

EJHaem

Physician perceptions and use of reduced-dose direct oral anticoagulants for extended phase venous thromboembolism treatment.

Research and practice in thrombosis and haemostasis

Clinical Outcomes of Critically III Patients with COVID-19 by Race.

Journal of racial and ethnic health disparities

Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study.

Blood advances

Immune thrombocytopenia in 2 healthy young women after the Pfizer-BioNTech BNT16B2b2 messenger RNA coronavirus disease 2019 vaccination.

Journal of the American College of Emergency Physicians open

Interdisciplinary Approach to Thrombosis Management in COVID-19 at a Large Academic Center.

JCO oncology practice

COVID-19-associated venous thromboembolism portends worse survival.

Seminars in vascular surgery

Risk of pulmonary emboli after removal of an upper extremity central catheter associated with a deep vein thrombosis.

Blood advances

North American Physician Practice Patterns in the Management of Anticoagulation in Pregnancy.

Journal of women's health (2002)

Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study.

Thrombosis research

Comanagement Strategy Between Academic Institutions and Community Practices to Reduce Induction Mortality in Acute Promyelocytic Leukemia.

JCO oncology practice

Venous Thromboembolism: Genetics and Thrombophilias.

Seminars in respiratory and critical care medicine

Therapeutic plasma exchange for COVID-19-associated hyperviscosity.

Transfusion

Fibrinolysis Shutdown and Thrombosis in a COVID-19 ICU.

Shock (Augusta, Ga.)

Validation of an admission coagulation panel for risk stratification of COVID-19 patients.

PloS one

Trends and diagnostic value of D-dimer levels in patients hospitalized with coronavirus disease 2019.

Medicine

Clinician-ordered peripheral blood smears have low reimbursement and variable clinical value: a three-institution study, with suggestions for operational efficiency.

Diagnostic pathology

Clinical Utilization and Cost of Thrombophilia Testing in Patients with Venous Thromboembolism.

TH open : companion journal to thrombosis and haemostasis

Outcomes of Chronic Phase Chronic Myeloid Leukemia after Treatment with Multiple Tyrosine Kinase Inhibitors.

Journal of clinical medicine

Rituximab leads to early elimination of circulating CD20+ T and B lymphocytes in patients with iTTP despite ongoing TPEx.

Blood advances

An uncommon presentation of chronic myeloid leukemia.

Annals of hematology

ERRATUM: Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation.

Hematology reports

Follow-up to comment on "Direct Oral Anticoagulants in Patients with Venous Thromboembolism and Thrombophilia: Systematic Review and Meta-Analysis".

Journal of thrombosis and haemostasis : JTH

Direct oral anticoagulants in patients with venous thromboembolism and thrombophilia: a systematic review and meta-analysis.

Journal of thrombosis and haemostasis : JTH

Outcomes of Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia Following an Elective Switch From Second-Generation Tyrosine Kinase Inhibitor to Imatinib.

Clinical lymphoma, myeloma & leukemia

Managing acute promyelocytic leukemia in patients belonging to the Jehovah's Witness congregation.

Hematology reports

Targeting 6-phosphogluconate dehydrogenase in the oxidative PPP sensitizes leukemia cells to antimalarial agent dihydroartemisinin.

Oncogene

Tetrameric Acetyl-CoA Acetyltransferase 1 Is Important for Tumor Growth.

Molecular cell

Predicting early blast transformation in chronic-phase chronic myeloid leukemia: is immunophenotyping the missing link?

Cancer

Disposable platform provides visual and color-based point-of-care anemia self-testing.

The Journal of clinical investigation

Venous access catheter-related thrombosis in patients with cancer.

Leukemia & lymphoma

Tyr phosphorylation of PDP1 toggles recruitment between ACAT1 and SIRT3 to regulate the pyruvate dehydrogenase complex.

Molecular cell

Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies.

Cancer

11/15/2024

Dr.Gadh is a competent physician, personable and very kind.

10/30/2024

Excellent experience and extremely accommodating!!

09/11/2024

She was very competent on all levels

09/04/2024

Dr. Gaddh provided amazing care an was very informative.

08/28/2024

I love Dr Gaddh! She is open to my concerns and genuinely cares about her patients

08/14/2024

She must of reviewed my file well, as she was well aware of my condition

07/12/2024

Dr Gaddh is always a good listener: she's generous with her time and patiently listens to my usual many questions and concerns, she takes what I have to say seriously and respectfully,And Provides detailed assessments, explanations and recommendations. She is an excellent clinician who genuinely cares.

06/14/2024

My care provider was extremely patient when answering my questions of concern. She was very professional and knowledgeable. She ease a lot of my anxiety concerning my prognosis.

04/27/2024

All questions were answered very well

04/13/2024

Very knowledgeable doctor.

04/13/2024

Dr. Gadh is an excelent hematologist

03/15/2024

Great experience with my doctor and her staff. I felt Assured with the level of concern and time spent going 9ver my medical history. This was first visit and I was extremely satisfied. Dr. GHADD TOOK TIME TO ADDRESS MY CONCERN AND HER APPROACH WHICH SHE FELT WOULD BE BEST MOVI G G FORWARD.

12/09/2023

Great

12/07/2023

She is very good! Very professional!! Love to have care from her.

12/07/2023

Good

11/30/2023

Dr Manila Gaddh represents one of the best Emory medical specialists I have visited. She listened carefully to my medical history and took excellent notes. She answered all my questions and provided excellent and thorough information about my medical issue. She provided an excellent summary and anticipatory guidance at the end of the visit. She also offered a diagnostic test to rule out a condition that I was concerned about due family medical history and my own recent medical history. I was very pleased with Dr Gaddh and would highly recommend her based on my visit.

11/17/2023

Dr Gaddh is a super competent and caring physician

10/12/2023

She made the visit very pleasant and easy

09/28/2023

Dr Gaddh is a very good doctor and answered all my questions and offered a solution to see if I can switch my warfarin to Eliquis

08/01/2023

Dr. Gaddh gives exemplary care. I could not be happier to have her as my hematologist!

07/13/2023

Dr Gaddh was excellent in listening and answering our concerns

06/15/2023

Care Provider very professional

06/09/2023

Dr Gaddth was the epitome of caring!

04/27/2023

Good

03/27/2023

Dr. Gaddh seemed inconvenienced by me. It was my first appointment so I had a hefty background to go through. She seemed to not be informed about my condition & other symptoms this condition causes according to more recent clinic studies & research. Despite my symptoms addressed she instantly wanted to revert my treatment down to medication that had been ineffective before. I advocated to keep treatment my prior Hematologist in another state had me on. She disagreed with my other doctor as far as diagnosis of comorbidity after only one appointment & no blood work. I'm a whole person, so I gave my full medical background because it all could relate to my condition. She was quick to say that's not my area for example my telling her about a tumor removed from my stomach. Dismissed many of my concerns with no explanation of why. She seemed bothered by me asking questions and wanting to be an Informed patient. She appeared to maybe be looking at old outdated information, it appeared as though there was some underlying prejudgement. Ultimately, she had cold bed side manner & because I didn't fit the stereotype for my condition she didn't seem to want to look into it further. Barely, looked at recent test result that I was concerned about. It was for sure a disappointment after waiting 5 months to get seen.

03/23/2023

The best and most knowledgeable doctor I've seen in 30 years, easily

01/27/2023

Dr Gaddh was very thorough and very good

01/06/2023

Dr. Gaddh gave me more information about an issue I was diagnosed with 6 years ago than the original doctors gave me when I was diagnosed to begin with - I really appreciated her thorough care.

01/04/2023

She was very attentive and very patient and knowledgeable about my illness